Particle.news
Download on the App Store
10 ARTICLES
·
3d ago

Synchron Debuts Native Thought-Controlled iPad With Apple’s BCI HID Protocol

The public demonstration marks the first time a minimally invasive Stentrode implant has enabled native iPad control in an FDA investigational trial involving ten participants.

Image
iPad thought control for ALS, paralyzed, patient, brain, mind
Stentrode converts brain signals into onscreen actions. Image: Synchron
Concept art of Synchron's Stentrode interface (Credit: Synchron).

Overview

  • In a video released August 4, Synchron showed Mark, an ALS patient in its COMMAND trial, navigating an iPad solely through thought using the Stentrode implant with Apple’s Switch Control feature.
  • The Stentrode device is delivered via catheter into a brain blood vessel to detect motor-intention signals and wirelessly transmit them to an external decoder that interfaces directly with iPadOS.
  • Under FDA investigational device exemptions, Synchron has implanted its endovascular BCI in ten patients across the United States and Australia without open-brain surgery.
  • Apple’s BCI HID protocol facilitates closed-loop communication by sharing real-time screen context back to the implant, enhancing precision and responsiveness of thought-driven inputs.
  • The milestone has intensified calls for comprehensive oversight of neural data ownership, privacy and cognitive rights beyond the FDA as consumer brain-computer interfaces near broader deployment.